Compound C108 – 1 mg

Brand:
Cayman
CAS:
15533-09-2
Storage:
-20
UN-No:
Non-Hazardous - /

Compound C108 is an inhibitor of the GTPase-activating protein (SH3 domain)-binding protein 2 (G3BP2), which is involved in breast tumor initiation.{34400} In a mouse xenograft model of breast cancer, compound C108 (1 µM for 24 hours) reduces the proportion of tumor-initiating cells approximately 10-fold compared with untreated cells. In MDA-MB-453 cells, and in the patient-derived xenograft cell line MAXF 401, it diminishes mammosphere formation.  

 

Available on backorder

SKU: 9002951 - 1 mg Category:

Description

A G3BP2 inhibitor; reduces tumor-initiating cells in a mouse xenograft model of breast cancer; diminishes mammosphere formation in MDA-MB-453 cells and a patient-derived xenograft cell line


Formal name: 2-hydroxy-benzoic acid, 2-[1-(2-hydroxyphenyl)ethylidene]hydrazide

Synonyms: 

Molecular weight: 270.3

CAS: 15533-09-2

Purity: ≥98%

Formulation: A crystalline solid